# Nuclide record idea-caix-theranostics (idea). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/ideas/idea-caix-theranostics/>
  a schema:CreativeWork ;
  nuclide:kind "idea" ;
  schema:identifier "idea-caix-theranostics" ;
  schema:name "CAIX theranostics: 89Zr-girentuximab PET and 177Lu/225Ac-girentuximab therapy"@en ;
  schema:description "Almost every clear-cell kidney cancer carries the CAIX protein. Image it with one radioactive antibody, then treat with the same antibody carrying a therapeutic isotope."@en ;
  schema:url <https://nuclide.cc/ideas/idea-caix-theranostics/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(24)00402-9> ;
  nuclide:related <https://nuclide.cc/isotopes/zr-89/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:indications <https://nuclide.cc/indications/rcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/caix-pet/>, <https://nuclide.cc/technologies/radioligand-therapy/>, <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/technologies/radioimmunotherapy/> ;
  nuclide:companies <https://nuclide.cc/companies/telix/> .